Biotechs need to build in data management from the outset
Biopharma start-ups need to identify the best data-management processes and systems – but to do so means they need to avoid the mistakes made by…
Pharma
Digital-Forward Pharma Will Outperform, if HCP Focus Stays Strong
The European Commission recently unveiled two long-awaited proposals on digital services and digital markets. While we don’t yet know how—or when—these measures will be enacted,…
How Virtual Engagement can Build Trust between CROs and Sponsors
Trust between clinical research organisations (CROs) and sponsors – a person or organisation that establishes and supports healthcare plans – is essential for running successful clinical…
Three Ways Med Tech can Improve the Public Image of Pharma
For pharmaceutical companies, negative publicity is always a risk. The success of research, trials and the rollout of a product is dependent on the trust…
BioSamples – The Block Between Bench and Bedside
A 2018 survey conducted by the UK agency Medicines Discovery Catapult found that 80% of SMEs (small to medium sized biotechs) found accessing biosamples from…
How AI and ML is Driving Value for Global Pharma Players
Today, we can enjoy innovations that were once considered science fiction, thanks to Data Science. Machine Learning (ML) and Artificial Intelligence (AI) have revolutionized the…
How Rep Relationships Open Digital Doors to HCPs
As the life sciences industry continues to embrace virtual interactions over the long term, digital is becoming more than just a way for field reps…
Digital Pharma Manufacturing Revolution In Cases
Top-level management from pharma companies and IT leaders from the manufacturing and packaging sector get together at Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2021) on…
Defining the Evolving Role of the Pharmacist
The pressures on overstretched NHS resources are well documented and well understood. With increasing focus on better integrated and connected care in the community, especially…
Proving Long-term Value in Advanced Therapies: Digital technologies can measure durability of effect
“Nature abhors a vacuum,” and health technology assessment (HTA) bodies and payers hate uncertainty. Unfortunately, when it comes to advanced therapy medicinal products (ATMPs), they…